The invention provides a method for predicting a hemorrhagic disorder in a patient consisting determining amine oxidase and, particularly, VAP-1 in a sample from said patient. The invention also provides pharmaceutical compositions comprising an inhibitor of amine oxidase and an antithrombotic agent as well as the use of an inhibitor of amine oxidase for treatment of hemorrhagic disorders.

Vilallonga; Joan Montaner

Hernandez-Guillamon; Mar

Lopez; Mercedes Unzeta

Universitat Autonoma de Barcelona

Methods and compositions for the treatment and diagnosis of haemorrhagic conversion

The invention provides compositions of matter having pharmacological activity and which are useful in the treatment of the symptoms of neurological and other disorders, particularly those disorders which are caused by malfunction of the immune mechanism. The present compositions include venoms and/or venom fractions extracted from various elapid and viperid snakes and generally include a postsynaptic component capable of binding to nicotinic acetylcholine receptors of cells, a presynaptic component capable of inhibition of acetylcholine release, and a viperid component stimulative of the immune system. According to the present invention, the viperid component of the present compositions of matter preferably constitutes a venom fraction which is absent certain enzymes such as L-amino acid oxidase and phosphodiesterase, these compositions being of particular utility due to the absence of a hemorrhagic effect when used in the treatment of mammals. Methods of preparation and use of the present compositions of matter are also disclosed.

oxidase/verenvuoto

Methods and compositions for the treatment and diagnosis of haemorrhagic conversion

Compositions for treatment of neurological and related disorders

Täydellisin lääketieteellinen tietokanta tieteen tukemana